FINANCIALS

YMAB Y-mabs Therapeutics Inc 1722964

Income Statement
Revenue	ymab-20240930x10q	18,461,000
Net Income	ymab-20240930x10q	-6,998,000
Profit Margin		-37.91%

Balance Sheet
Current Assets	99,057,000
Assets	120,917,000
Current Liabilities	25,292,000
Liabilities	28,488,000
Equity	92,429,000
Shares Out	44,570,000

Cash Flow Statement
Operating Cash Flow	-13,844,000

Market Analysis
Market Cap	626,206,120
Price	6.16
BVPS	2.07
PB	2.93
EPS	-0.56
PS	8.48

Dividends

Earnings

Find a discrepancy? The most accurate way to find company fundamental data is to view YMAB documents filed with the SEC.

YMAB Filings Clear

View A List of Tickers